Menu
Enrolling by invitation NCT06735573

Protein, Sarcopenic Obesity, and COPD

Observational Sarcopenic Obesity Chronic Obstructive Pulmonary Diseases

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: the relationship between the quantity and source of dietary protein intake, and the prevalence of sarcopenic obesity, and lung function outcomes.
Who it may be relevant to
Registry conditions: Sarcopenic Obesity, Chronic Obstructive Pulmonary Diseases. Basic parameters: from 55 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Observational Study to Explore the Relationship Between Dietary Protein Intake and the Prevalence of Sarcopenic Obesity in Adult Female With Chronic Obstructive Pulmonary Disease (COPD): A Pilot Study

Overview

Both sarcopenic obesity and chronic obstructive pulmonary diseases (COPD) are common conditions that mainly affect middle-aged and older adults. Previous research has shown that increased dietary intake of total and plant-based protein is associated with a lower risk of sarcopenic obesity, using data from the EPIC Norfolk study. Furthermore, a systematic review and meta-analysis showed that having sarcopenic obesity was associated with significantly impaired lung function outcomes. Other research has shown that increased intake of dietary protein leads to a better treatment outcome for respiratory diseases. The aim of this pilot observational study is to investigate, in more detail, the relationship between the quantity and source of dietary protein intake, the prevalence of sarcopenic obesity, and lung function, in a small cohort of older female participants with COPD. The study will also consider the role of inflammation in relation to sarcopenic obesity and lung function outcomes. This study will help to improve the understanding of the relationship between sarcopenic obesity and lung function outcomes, and how dietary protein intake and inflammation can affect this relationship and each of the outcomes.

Interventions

  • Other the relationship between the quantity and source of dietary protein intake, and the prevalence of sarcopenic obesity, and lung function outcomes
    Primary Objective The primary objective is to measure the relationship between the quantity and source of dietary protein intake, and the prevalence of sarcopenic obesity, and lung function outcomes, in older female participants with clinically diagnosed COPD. Secondary Objectives The secondary objective is to investigate whether the level of inflammation (plasma CRP) is associated with the intake of total, plant-based and animal-based protein, with the prevalence of sarcopenic obesity, and wit

Primary outcome measures

  • Association between dietary protein and the prevalence of sarcopenic obesity [Time frame: through study completion, an average of 1 year]
Secondary outcome measures (1)
  • Association between dietary protein and lung functions outcomes [Time frame: through study completion, an average of 1 year]

Eligibility criteria

Inclusion criteria

  • Women.
  • Clinically diagnosed with COPD.
  • Aged 55 years or older.

Exclusion criteria

  • Male.
  • Women who are 54 years or younger.
  • Those who have dementia.
  • Unable to read or write in English.
  • Unable to attend the Human Intervention Studies Unit.
  • Those within one year life expectancy.
  • Those who have cancer.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

United Kingdom · 1 center
  • Baukje de Roos — Aberdeen

Identifiers

NCT: NCT06735573 · T Baabbad · University of Aberdeen

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗